Virus-mimicking drug helps immune system target cunning cancer cells
Researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, have found that a drug that…
Browsing: Immunotherapy
CAR NKT cells offer a promising novel immunotherapy for solid tumours
Natural killer T (NKT) cells, a type of immune cells known for their potent anti-cancer…
Cancer-killing T cells ‘swarm’ to tumours, attracting others to the fight
When immune system T cells find and recognise a target, they release chemicals to attract…
Dual checkpoint blockade promising as pre-surgical approach for certain patients with localised bladder cancer
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1)…
Ludwig study finds a common nutritional supplement might boost cancer immunotherapy
A Ludwig Cancer Research study has uncovered a mechanism by which the tumour’s harsh internal…
ESMO 2020: Preliminary results of two large immune therapy studies show promise in advanced cervical cancer
Preliminary results from two independent, phase II clinical trials investigating a new PD-1 (programmed cell…
Study identifies characteristics of infused CAR-T cells associated with efficacy and toxicity in patients with large B-cell lymphoma
Researchers at The University of Texas MD Anderson Cancer Center, USA, have identified molecular and…
Cancer immunotherapy ‘uniquely suppressed’ by liver tumours
Though cancer immunotherapy has become a promising standard-of-care treatment – and in some cases, perhaps…
FDA grants Fast Track designation to Calibr’s ‘switchable’ CAR-T cell cancer therapy
The U.S. Food and Drug Administration has granted Fast Track designation to a novel “switchable”…
Prostate cancer: immunotherapy offers hope
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant…